Homologous recombination-DNA damage response defects increase TMB and neoantigen load, but not effector T cell density and clonal diversity in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to chemotherapy. However, PDAC with germline BRCA mutations, which lead to homologous recombination (HR) deficiency (HRD), demonstrated an increased sensitivity to platinum-based chemotherapy regimens. This increased chemosensitivi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mengyue Lei, Jessica Gai, Thomas J. McPhaul, Huijuan Luo, Penghui Lin, Dongbing Liu, Michael Pishvaian, Nicholas J. Roberts, Kui Wu, Jin He, Lei Zheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-06-01
coleção:	Experimental Hematology & Oncology
Assuntos:	Pancreatic ductal adenocarcinoma (PDAC) Homologous recombination-DNA damage response defects Tumor mutation burden (TMB) T cell infiltration T cell clonal diversity Immune checkpoint inhibitors
Acesso em linha:	https://doi.org/10.1186/s40164-025-00673-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!